1. Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database. Issue 5 (May 2016) Authors: Wolff, I.; May, M.; Hoschke, B.; Zigeuner, R.; Cindolo, L.; Hutterer, G.; Schips, L.; De Cobelli, O.; Rocco, B.; De Nunzio, C.; Tubaro, A.; Coman, I.; Feciche, B.; Truss, M.; Dalpiaz, O.; Figenshau, R.S.; Madison, K.; Sánchez-Chapado, M.; Santiago Martin, M.D.C.; Salzano, L. Journal: European journal of surgical oncology Issue: Volume 42:Issue 5(2016:May) Page Start: 744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of an ongoing ERAS® society implementation program on early outcomes in bariatric surgery. (October 2022) Authors: Gentile, I.; Rossini, R.; Menestrina, N.; Lodi, G.; Tubaro, A.; Zuppini, T.; Bonadiman, S.; Misso, A.; Ruffo, G. Journal: Clinical nutrition ESPEN Issue: Volume 51(2022) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In vitro effects of three azaspiracid analogues on hepatocytes. (15th June 2016) Authors: Pelin, M.; Sosa, S.; Brovedani, V.; Kilcoyne, J.; Nulty, C.; Hess, P.; Tubaro, A. Journal: Toxicon Issue: Volume 116(2016) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Issue 2 (11th December 2014) Authors: Bunn, F.; Kirby, M.; Pinkney, E.; Cardozo, L.; Chapple, C.; Chester, K.; Cruz, F.; Haab, F.; Kelleher, C.; Milsom, I.; Sievart, K. D.; Tubaro, A.; Wagg, A. Journal: International journal of clinical practice Issue: Volume 69:Issue 2(2015) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LP-63 Reduction and formulation of graphene oxide modulate its cytotoxicity towards bronchial cells. (1st September 2022) Authors: Carlin, M.; Passerino, C.; Sosa, S.; Tubaro, A.; Catalan, J.; Pelin, M. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Monitoring compliance during an ongoing ERAS® society implementation program: Adherence to ERAS protocol improves clinical outcomes in colorectal surgery. (October 2022) Authors: Bertocchi, E.; Barugola, G.; Masini, G.; Menestrina, N.; Tubaro, A.; Lodi, G.; Zuppini, T.; Bonadiman, S.; Misso, A.; Ruffo, G. Journal: Clinical nutrition ESPEN Issue: Volume 51(2022) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice. (3rd January 2014) Authors: Zecca, C.; Digesu, G. A.; Robshaw, P.; Puccini, F.; Khullar, V.; Tubaro, A.; Gobbi, C. Journal: European journal of neurology Issue: Volume 21:Number 3(2014:Mar.) Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC-0146: The PROS-IT CNR study: comorbidities and medications at the time of diagnosis of prostate cancer. (April 2016) Authors: Magrini, S.; Ricardi, U.; Bertoni, F.; Corvò, R.; Russi, E.; Santoni, R.; Artibani, W.; Bassi, P.; Bracarda, S.; Conti, G.; Gacci, M.; Graziotti, P.; Maggi, S.; Mirone, V.; Montironi, R.; Muto, G.; Noale, M.; Pecoraro, S.; Porreca, A.; Tubaro, A. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Toxic equivalency factors (TEFs) after acute oral exposure of azaspiracid 1, −2 and −3 in mice. (5th January 2018) Authors: Pelin, M.; Kilcoyne, J.; Nulty, C.; Crain, S.; Hess, P.; Tubaro, A.; Sosa, S. Journal: Toxicology letters Issue: Volume 282(2018) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset. Issue 11 (November 2016) Authors: Simone, G.; De Nunzio, C.; Ferriero, M.; Cindolo, L.; Brookman-May, S.; Papalia, R.; Sperduti, I.; Collura, D.; Leonardo, C.; Anceschi, U.; Tuderti, G.; Misuraca, L.; Dalpiaz, O.; Hatzl, S.; Lodde, M.; Trenti, E.; Pastore, A.L.; Palleschi, G.; Lotrecchiano, G.; Salzano, L. Journal: European journal of surgical oncology Issue: Volume 42:Issue 11(2016:Nov.) Page Start: 1729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗